Derek Bagley, Author at Endocrine News

Software Company Simplifies Glycemic Management for Clinicians and Pharmacists

In August, the insulin management software company Glytec unveiled the latest version of its Glucommander insulin dosing software to make it easier for providers, nurses, and pharmacists to offer optimal, personalized care. More than 300 hospitals in the U.S. use Glytec’s eGlycemic Management System® (eGMS®) for glycemic management for their patients. Glytec chief medical officer...

Good Sports

A new book spotlights athletes thriving with diabetes. In the new book, Winning with Diabetes: Inspiring Stories from Athletes to Help You Thrive, Rita R. Kalyani, MD, MHS; Mark D. Corriere, MD; and Patrick Smith have created an inspirational handbook that clinicians can share with their patients to help them overcome the challenges they may...

Women Face Greater Risk of Obesity in Low- and Middle-Income Countries

Study finds women are 2-3 times more likely to be affected than men Women in low- and middle-income countries, especially in the Sub-Saharan Africa region, may be 10 times more likely to have obesity or heart health issues than their male counterparts, according to a large meta-analysis published in The Journal of Clinical Endocrinology and Metabolism....

Lonapegsomatropin Provides Height Improvements in Later Tanner Stages without Increase in Dose

Lonapegsomatropin, a once-weekly prodrug of somatropin, can help children in Tanner Stages 3-5 maintain consistent height standard deviation scores (SDS) without an increase in the mean dose, according to a study presented at ENDO 2023. Ascendis Pharma is marketing the drug as TransCon hGH. Researchers led by Paul Hofman, MD, FRACP, of the Liggins Institute...

Children with Achondroplasia See Improved Annual Height Velocity with Investigational Prodrug

Children with achondroplasia (ACH), the most common form of hereditary short stature, experienced statistically significant improvements in their annual height velocity with the prodrug TransCon CNP, according to a study presented at ENDO 2023. Ascendis Pharma is investigating the drug in the Phase 2 ACcomplisH trial. Researchers led by Ravi Savarirayan, MBBS, FRACP, MD, of...

COVID-19 Vaccines and Hyperglycemia in Patients with Type 1 Diabetes

While proven to be safe, the COVID-19 vaccines could cause some people with type 1 diabetes to see their blood sugar to temporarily spike. The key for both patient and provider is to remain vigilant with glucose testing and insulin dosing post-jab to maintain glycemic control. In the summer of 2021, a 24-year-old woman presented...

UK Joins Horizon Europe Under New Bespoke Deal

United Kingdom scientists will have access to the world’s largest research collaboration program, Horizon Europe, as the Prime Minister secures a bespoke deal with improved financial terms for the UK’s participation. UK researchers can now apply for grants and bid to take part in projects under the Horizon program, with certainty that the UK will...

Obesity Appears to Increase the Risk of Developing Polycystic Ovary Syndrome

Obesity appears to increase the risk of developing polycystic ovary syndrome (PCOS), according to a study presented at ENDO 2023. An estimated 7% to 10% of all reproductive-aged women globally have PCOS. Women with PCOS have a hormonal imbalance and metabolism problems that may affect their overall health, appearance, and fertility. PCOS is associated with health...